GLP-2T Peptide

Overview

GLP-2T Tirzepatide peptide is a dual-receptor agonist compound supplied for controlled laboratory and in vitro research environments. Current GLP-2T peptide research focuses on its interaction with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor pathways, enabling the study of coordinated incretin-related signaling and peptide-mediated pathway dynamics.

Also known as LY3298176, GLP-2T peptide is studied in laboratory models examining receptor binding behavior, intracellular signaling cascades, and molecular response pathways under controlled experimental conditions.

GLP-2T peptide is frequently referenced in research literature examining peptide-based signaling interactions under controlled laboratory conditions.

GLP-2T Peptide Receptor Interaction Research Context

Research involving GLP-2T Tirzepatide peptide examines its binding interactions across the GLP-1 and GIP receptors, enabling laboratory study of receptor binding affinity, binding selectivity, and comparative activity across the two receptor targets. Studies focus on measurable molecular endpoints such as receptor-binding behavior and in vitro signaling readouts under controlled laboratory conditions.

Experimental models are used to compare relative binding selectivity across the two receptor classes and to characterize GLP-2T Tirzepatide peptide behavior in controlled binding and signaling assays.

Additional Research Considerations

Current investigations focus on how dual-receptor peptide compounds behave in defined in vitro binding and signaling assays, including receptor selectivity profiling and assay reproducibility across controlled laboratory models.

Research efforts are also focused on understanding how variations in experimental design, concentration, and molecular stability may affect peptide behavior across different in vitro systems and analytical frameworks.

Further scientific literature related to incretin and dual-receptor peptide research can be accessed through established databases such as
PubMed, where ongoing studies and experimental findings are published.

Research Applications

• Incretin-related signaling pathway analysis
• GLP-1 and GIP receptor interaction studies
• Cellular response modeling in controlled in vitro environments
• Peptide stability and degradation research
• Molecular characterization and assay development

Product Specifications

• Quantity: 10 mg, 20 mg, 30 mg, 40 mg, 60 mg, or 100 mg vial
• Form: Lyophilized powder
• Purity: ≥99% (HPLC)
• Solubility: Soluble in compatible aqueous buffers
• Characterization: HPLC, Mass Spectrometry
• CAS Number: 2023788-19-2

Storage and Handling

Store at −20 °C (−4 °F) or below. Store in the original vial, sealed and protected from light and moisture until use. Avoid repeated freeze-thaw cycles.

Related Research Compounds

GLP-2T is our house designation for tirzepatide, a dual GIP and GLP-1 receptor agonist research compound. It is frequently studied alongside other peptide compounds in laboratory research environments. Related compounds may include GLP-1S (Semaglutide) and GLP-3R (Retatrutide).

• Explore GLP-1S (Semaglutide)
• Explore GLP-3R (Retatrutide)

Research reading:

• Semaglutide vs Tirzepatide: Research Pathway Differences
• Retatrutide vs Tirzepatide: Triple Agonist vs Dual Agonist Research
• GLP-1 Research Compounds: From Semaglutide to Retatrutide

This compound is part of our Peptides research category, which includes a range of laboratory-grade peptide compounds studied in controlled environments.

GLP-2T peptide continues to be studied in research settings focused on incretin-related signaling pathways, receptor interaction frameworks, and peptide-mediated pathway analysis under controlled laboratory conditions.

Frequently Asked Questions

What is GLP-2T peptide used for in research?

GLP-2T peptide is studied in laboratory environments for its interaction with GLP-1 and GIP receptor pathways and its role in incretin-related signaling systems.

How is GLP-2T peptide supplied?

This product is supplied as a lyophilized powder for controlled laboratory research use.

Is GLP-2T peptide for human use?

No. This product is strictly for research use only and is not intended for human or veterinary use.

Disclaimer, Intended Use & Terms of Sale

All content and information provided are for educational and research reference purposes only. This product and its associated data have not been evaluated by the U.S. Food and Drug Administration, and no claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. No representations or warranties are made regarding safety, effectiveness, or outcomes.

This product is intended strictly for in vitro laboratory research use only and is not for clinical use. It is not approved for human or animal administration and must not be used in food, dietary supplements, pharmaceuticals, cosmetics, or any consumer applications.

By purchasing from Badger Compounds, the buyer affirms that they are a qualified researcher or institution with the appropriate training, facilities, and authorization to handle research compounds in compliance with all applicable laws and regulations. All sales are final.